Spots Global Cancer Trial Database for adenocarcinoma of esophagogastric junction
Every month we try and update this database with for adenocarcinoma of esophagogastric junction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma | NCT04813523 | Adenocarcinoma ... Neoadjuvant Che... Pembrolizumab | Pembrolizumab I... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05970627 | Adenocarcinoma ... Adenocarcinoma ... Epstein-Barr Vi... | Toripalimab Oxaliplatin S1 | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
| Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma | NCT05505461 | Adenocarcinoma ... | neoadjuvant Rad... | 18 Years - 75 Years | Peking University People's Hospital | |
| A Modified Esophagogastric Reconstruction Method After Laparoscopic Proximal Gastrectomy | NCT05829213 | Proximal Gastri... Adenocarcinoma ... Anastomosis | "arch-bridge-ty... | 18 Years - 75 Years | Peking University | |
| A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors | NCT03734913 | Basal Cell Carc... Medulloblastoma Adenocarcinoma ... Small Cell Lung... Neuroendocrine ... Glioblastoma | ZSP1602 | 18 Years - 75 Years | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | |
| Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA | NCT06222944 | Gastric Cancer Adenocarcinoma ... | Anlotinib TQB2450 Albumin-Bound P... | 18 Years - 75 Years | Peking University | |
| Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA | NCT06222944 | Gastric Cancer Adenocarcinoma ... | Anlotinib TQB2450 Albumin-Bound P... | 18 Years - 75 Years | Peking University | |
| A Modified Esophagogastric Reconstruction Method After Laparoscopic Proximal Gastrectomy | NCT05829213 | Proximal Gastri... Adenocarcinoma ... Anastomosis | "arch-bridge-ty... | 18 Years - 75 Years | Peking University | |
| Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | NCT00411151 | Gastric Adenoca... Barrett Esophag... | Sunitinib-Malat... | 18 Years - | Johannes Gutenberg University Mainz | |
| A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors | NCT03734913 | Basal Cell Carc... Medulloblastoma Adenocarcinoma ... Small Cell Lung... Neuroendocrine ... Glioblastoma | ZSP1602 | 18 Years - 75 Years | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | |
| Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma | NCT05505461 | Adenocarcinoma ... | neoadjuvant Rad... | 18 Years - 75 Years | Peking University People's Hospital | |
| Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | NCT01095120 | Adenocarcinoma ... Adenocarcinoma ... | Tesetaxel | 18 Years - | Genta Incorporated | |
| A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique | NCT06300879 | Gastric Cancer Adenocarcinoma ... | Performing tota... | 18 Years - 75 Years | Huashan Hospital | |
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | NCT03302403 | B Cell Lymphoma B Cell Leukemia Myeloma Hepatocellular ... Pancreatic Carc... Adenocarcinoma ... | CAR-CD19 T cell CAR-BCMA T cell CAR-GPC3 T cell CAR-CLD18 T cel... Fludarabine Cyclophosphamid... | 18 Years - 75 Years | First Affiliated Hospital of Wenzhou Medical University | |
| Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) | NCT05872685 | Adenocarcinoma ... Adenocarcinoma ... Proficient Mism... | S1 Oxaliplatin Serplulimab Placebo | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
| Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction | NCT01697917 | Adenocarcinoma ... | Total Gastrecto... | 20 Years - 75 Years | Fudan University | |
| Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05715931 | Adenocarcinoma ... Adenocarcinoma ... HER2-positive G... | Toripalimab Trastuzumab 5-FU, leucovori... | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
| Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma | NCT04813523 | Adenocarcinoma ... Neoadjuvant Che... Pembrolizumab | Pembrolizumab I... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
